Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CD74

CD74, also known as the invariant chain that is associated with MHC class II molecules, is a non-polymorphic glycoprotein primarily expressed on antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells. It plays a crucial role in the synthesis and transport of MHC class II molecules, facilitating their movement from the endoplasmic reticulum to the cell surface. Within the endoplasmic reticulum, CD74 forms a trimeric complex with the α and β chains of MHC class II molecules, preventing premature binding of endogenous peptide fragments to MHC class II molecules intracellularly. Furthermore, CD74 participates in regulating immune responses by forming signalling complexes with molecules such as CD44 and CD91, thereby influencing cellular activation, proliferation, and inflammatory signalling pathways. In oncology, the abnormal expression of CD74 in various tumour cells correlates with tumour progression and prognosis.

Milatuzumab
T77478899796-83-9
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
  • $289
In Stock
Size
QTY
4-CPPC
T3829329553-70-6
4-CPPC is an inhibitor of macrophage migration inhibitory factor-2 (MIF-2; IC50= 27 μM).1It is selective for MIF-2 over MIF-1 (IC50= 450 μM). It inhibits MIF-2, but not MIF-1, binding to CD74in vitrowhen used at a concentration of 10 μM. 4-CPPC (5, 10, and 25 μM) inhibits MIF-2-induced ERK1/2 phosphorylation in primary human skin fibroblasts. 1.Tilstam, P.V., Pantouris, G., Corman, M., et al.A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activityJ. Biol. Chem.294(49)18522-18531(2019)
  • $51
In Stock
Size
QTY